ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes

Developer of sustainable cell-free enzyme technology pursuing uses that include active ingredients for nutraceuticals and pharmaceuticals, CEO Michael Heltzen tell GEN Edge